Skip to main content
SpringerLink
Log in

The shape of age–incidence curves of female breast cancer by hormone-receptor status

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objectives: Substantial decline of ovarian hormones at menopause plays an important role in breast cancer etiology. Hormones must bind to specific receptors to elicit biological responses, however. We therefore hypothesized and examined whether the age-specific risk of breast cancer, especially its change at menopause, differs by estrogen and progesterone receptor (ER/PR) status.

Methods: Age-specific incidence rates, stratified by ER/PR status, were estimated by multiplying the age-specific ER/PR distribution among 3359 cases in the Danish Breast Cancer Cooperative Group by Danish national age-specific incidence rates. International variations in the age–incidence curve were also reviewed in relation to the hypothesis.

Results: The incidence of ER + /PR + subtype (62.9% of all cases) increased with age continually, with a sudden decrease in the rate of increase around age 44. The incidence of ER − /PR − subtype (17.6%) increased with age prior to about age 50 but remained unchanged subsequently. The incidence of ER + /PR− subtype (13.9%) increased rapidly during the menopausal period but only slightly afterwards. The incidence of ER − /PR + subtype (5.6%) increased until about age 43 and decreased subsequently. The international comparison revealed Western women, particularly the elderly, might be at substantially higher risk for ER + /PR + subtype compared to Japanese women.

Conclusion: Age-specific risk of breast cancer differs by ER/PR status. The large international variation of breast cancer incidence rates may be explained largely by the risk difference for ER + /PR + subtype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Clemmesen J (1948) The Danish Cancer Registry. Problems and results. Acta Pathol Microbiol Scand 25: 26-33.

    Google Scholar 

  2. Key TJA, Pike MC (1988) The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29-43.

    Google Scholar 

  3. Thomas DB (1993) Breast cancer in men. Epidemiol Rev 15: 220-231.

    Google Scholar 

  4. Habel LA, Stanford JL (1993) Hormone receptors and breast cancer. Epidemiol Rev 15: 209-219.

    Google Scholar 

  5. Zhu K, Bernard LJ, Levine RS, Williams SM (1997) Estrogen receptor status of breast cancer: a marker of different stages of tumor or different entities of the disease? Med Hypotheses 49: 69-75.

    Google Scholar 

  6. Potter JD, Cerhan JR, Sellers TA, et al. (1995) Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 4: 319-326.

    Google Scholar 

  7. Huang WY, Newman B, Millikan RC, Schell MJ, Moorman PG (1998) Hormone-related factors and risk of breast cancer by estrogen receptor and progesterone receptor status. Am J Epidemiol 147: S35.

    Google Scholar 

  8. Gapstur SM, Potter JD, Drinkard C, Folsom AR (1995) Synergism between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 4: 313-318.

    Google Scholar 

  9. Enger SM, Ross RK, Paganini-Hill A, Longnecker, MP, Bernstein L (1998) Breast cancer risk associated with alcohol consumption depends on hormone receptor status. (abstract) Am J Epidemiol 147(11): S35.

    Google Scholar 

  10. Trentham-Dietz A, Newcomb PA, Sabatini LM, Gilchrist K (1998) Hormone replacement therapy and risk of postmenopausal breast cancer according to estrogen and progesterone receptor status. Proc Am Assoc Cancer Res 39: 101.

    Google Scholar 

  11. Robertson JF (1996) Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer 73: 5-12.

    Google Scholar 

  12. Thorpe SM (1988) Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance. Acta Oncol 27: 1-19.

    Google Scholar 

  13. Danish Cancer Registry (1983) Cancer Incidence in Denmark 1978, 1979 and 1980. Copenhagen: Danish Cancer Society.

    Google Scholar 

  14. Danish Cancer Registry (1985) Cancer Incidence in Denmark 1981 and 1982. Copenhagen: Danish Cancer Society.

    Google Scholar 

  15. Danish Cancer Registry (1987) Cancer Incidence in Denmark 1983. Copenhagen: Danish Cancer Society.

    Google Scholar 

  16. Danish Cancer Registry (1987) Cancer Incidence in Denmark 1984. Copenhagen: Danish Cancer Society.

    Google Scholar 

  17. Danish Cancer Registry (1988) Cancer Incidence in Denmark 1985. Copenhagen: Danish Cancer Society.

    Google Scholar 

  18. Storm HH, Sprøgel P, Bang S, Jensen OM (eds) (1989) Cancer Incidence in Denmark 1986. Copenhagen: Danish Cancer Society.

    Google Scholar 

  19. Storm HH, Manders T, Sprøgel P, Bang S, Jensen OM (eds) (1990). Cancer Incidence in Denmark 1987. Copenhagen: Danish Cancer Society.

    Google Scholar 

  20. Parkins DM, Muir CS, Whelan SL, Gao YT, Ferlay J (eds) (1993) Cancer Incidence in Five Continents. VI. IARC Scientific Publications, Vol. 120. Oxford: Oxford University Press.

    Google Scholar 

  21. Moolgavkar SH (1986) Hormones and multistage carcinogenesis. Cancer Surv 5: 635-648.

    Google Scholar 

  22. Horwitz KB, McGuire WL (1978) Estrogen control of progesterone receptor in human breast cancer: correlation with nuclear processing of estrogen receptor. J Biol Chem 253: 2223-2228.

    Google Scholar 

  23. Potischman N, Swanson CA, Siiteri P, Hoover RN (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88: 756-758.

    Google Scholar 

  24. Giuffrida D, Lupo L, La Porta GA, et al. (1992) Relation between steroid receptor status and body weight in breast cancer patients. Eur J Cancer 28: 112-115.

    Google Scholar 

  25. Fuqua SAW, Fitzgerald SD, Chamness GC, et al. (1991) Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 51: 105-109.

    Google Scholar 

  26. Nomura Y, Miura S, Koyama H, et al. (1992) Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. Cancer 69: 153-164.

    Google Scholar 

  27. Nomura Y, Kobayashi S, Takatani O, Sugano H, Matsumoto K, McGuire WL (1977) Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients. Cancer Res 37: 106-110.

    Google Scholar 

  28. Nagata C, Matsushita Y, Shimizu H (1996) Prevalence of hormone replacement therapy and user's characteristics: a community survey in Japan. Maturitas 25: 201-207.

    Google Scholar 

  29. Harris RB, Laws A, Reddy VM, King A, Haskell WL (1990) Are women using postmenopausal estrogens? A community survey. Am J Public Health 80: 1226-1228.

    Google Scholar 

  30. Koster A (1990) Hormone replacement therapy: use patterns in 51-year-old Danish women. Maturitas 12: 345-356.

    Google Scholar 

  31. Männistö S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, Uusitupa M (1996) Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer 68: 8-13.

    Google Scholar 

  32. Ricketts D, Turnbull L, Ryall G, et al. (1991) Estrogen and progesterone receptors in the normal female breast. Cancer Res 51: 1817-1822.

    Google Scholar 

  33. Petersen OW, Høyer PE, van Deurs B (1987) Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 47: 5748-5751.

    Google Scholar 

  34. Clarke RB, Howell A, Potten CS, Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57: 4987-4991.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, USA

    Yutaka Yasui & John D. Potter

Authors
  1. Yutaka Yasui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John D. Potter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yasui, Y., Potter, J.D. The shape of age–incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control 10, 431–437 (1999). https://doi.org/10.1023/A:1008970121595

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008970121595

Search

Navigation